Detection of aminoglycoside ototoxicity by high-frequency auditory evaluation: Selected case studies**

https://doi.org/10.1016/S0196-0709(84)80009-5Get rights and content

A practical monitoring procedure utilizing frequencies higher than those tested by conventional audiometry for the detection of ototoxicity has the potential for preventing or minimizing irreversible communication deficits in patients receiving aminoglycoside antibiotic therapy. If ototoxicity produced by these drugs could be detected before it progresses to involve the frequencies essential for communication, it might be possible to lower the dose or to change to another antibiotic to prevent a permanently handicapping hearing impairment. From a total of 77 patients monitored by serial audiograms, three case studies illustrate the various types of auditory sensitivity changes observed with high-frequency audiometry. Ototoxicity was generally detected by high-frequency auditory testing before it could be detected by conventional audiometric procedures. These cases demonstrate the utility of monitoring audition at frequencies higher than those tested conventionally in patients receiving aminoglycoside antibiotics.

References (18)

  • JickH et al.

    Boston Collaborative Drug Surveillance Program: drug induced deafness

    JAMA

    (1973)
  • JacksonGG et al.

    Ototoxicity of gentamicin in man: a survey and controlled analysis of clinical experience in the United States

    J Infect Dis

    (1971)
  • FeeWE

    Aminoglycoside ototoxicity in the human

    Laryngoscope

    (1980)
  • KuminGD

    Clinical nephrotoxicity of tobramycin and gentamicin

    JAMA

    (1980)
  • FrostJO et al.

    The ototoxicity of kanamycin in man

    Antibiot Annual

    (1958–1959)
  • JacobsonEJ et al.

    Clinical findings in high-frequency thresholds during known ototoxic drug usage

    J Aud Res

    (1969)
  • WilsonP et al.

    Immediate effects of tobramycin on human cochlea and correlation with serum tobramycin levels

    Br Med J

    (1977)
  • BarzaM et al.

    Why monitor serum levels of gentamicin?

    Clin Pharmacokinet

    (1978)
  • HewittWL

    Gentamicin: toxicity in perspective

    Postgrad Med J

    (1974)
There are more references available in the full text version of this article.

Cited by (54)

  • Extended high frequency hearing and speech perception implications in adults and children

    2020, Hearing Research
    Citation Excerpt :

    By the second decade of life, significant decreases in sensitivity have occurred, and continue to progress in a basal to apical pattern. EHF hearing is highly susceptible to ototoxic drugs (Fausti et al., 1993, 1984; Garinis et al., 2018) otitis media with effusion (Cordeiro et al., 2018; Hunter et al., 1996) and impulse noise due to firearm use (Fausti et al., 1981; Laffoon et al., 2019). However, variability of the impact to EHF hearing is large among all these risk factors, presumably due to genetic variants.

  • Inner Hair Cell and Neuron Degeneration Contribute to Hearing Loss in a DFNA2-Like Mouse Model

    2019, Neuroscience
    Citation Excerpt :

    This result can be associated with the initial reduction of hearing sensitivity (< 60 dB) at high frequencies, which progresses to middle and low frequencies with age in DFNA2 patients (Dominguez and Dodson, 2012). Also, ototoxic drugs that alter KCNQ4 channel function exhibit a similar degenerative profile, where OHCs from basal turns are more sensitive to their deleterious effects (Fausti et al., 1984; Leitner et al., 2011; Sheppard et al., 2015). However, this expression pattern differs from that reported by others.

  • High frequency hearing thresholds and product distortion otoacoustic emissions in cystic fibrosis patients

    2015, Brazilian Journal of Otorhinolaryngology
    Citation Excerpt :

    HFA evaluates pure tone air conduction thresholds in the 9–20 kHz range, depending on the equipment. This is an important test for the early detection of hearing loss caused by damage to the base of the cochlea, as occurs in cases of ototoxicity, because it allows the detection of hearing loss before reaching the conventionally measured frequency range (250–8000 Hz).15,16 The literature presents some studies on CF patients evaluating hearing by HFA.

  • Generation of highly-reactive oxygen species is closely related to hair cell damage in rat organ of corti treated with gentamicin

    2009, Neuroscience
    Citation Excerpt :

    Even with the use of neonatal HCs, in our chronic experiment we observed fluorescence consistent with hROS formation that was most prominent in OHCs, was graded from base to apex, and was furthermore graded from the first to the third row of OHCs and IHCs. All of these features reflect the sensitivity of HCs to GM in the in vivo cochlea (e.g. Fausti et al., 1984; Hinojosa et al., 2001). Our studies confirm previous in vitro findings (Richardson and Russell, 1991; Forge and Richardson, 1993; Battaglia et al., 2003) of differential HC sensitivity to aminoglycoside damage.

  • Antioxidant gene therapy can protect hearing and hair cells from ototoxicity

    2004, Molecular Therapy
    Citation Excerpt :

    A serious limitation in the treatment with aminoglycoside antibiotics is their potential nephrotoxic and ototoxic side effects [1–3]. Aminoglycoside-induced hearing loss and inner ear pathology have been well studied in humans and animal models [3–5]. The lesion usually starts from the base of the cochlea and, correspondingly, high frequencies are affected first and to a greater extent.

View all citing articles on Scopus
**

Supported by the Medical Research Service of the Veterans Administration.

*

Audiology Research Laboratory, VA Medical Center, 3710 S.W. U.S. Veterans Hospital Road, Portland, OR 97201.

Infections Disease Section, Portland VA Medical Center.

Kresge Hearing Research Laboratory, Oregon Health Sciences University.

View full text